Sequelae from meningococcal meningitis in children: A critical analysis of dexamethasone therapy

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 2 B, 2004, Pages 421-428

  Barbante Casella, Erasmo ^a,b   Cypel, Saul ^a   Osmo, André Alexandre ^a   Okay, Yassuhiko ^a   Lefèvre, Beatriz Helena ^a   Lichtig, Ida ^a   Marques Dias, Maria Joaquina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Neurology Department ^*  (Brazil)

Author keywords

Dexamethasone; Meningococcal meningitis; Sequelae

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; DEXAMETHASONE; PENICILLIN G;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EPIDEMIC MENINGITIS; FEMALE; HAEMOPHILUS INFLUENZAE; HEARING LOSS; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; STEROID THERAPY; STREPTOCOCCUS PNEUMONIAE; SURVIVAL;

EID: 3142784548     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000300009     Document Type: Article

References (32)

1. Lebel MH, Freji GJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med. 1988;319:964-971.
2. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989;8:848-851.
3. Kaplan SL. Dexamethasone for children with bacterial meningitis should it be routine therapy? AJDC. 1989;143:290-292.
4. Kennedy WA, Hoyt MJ, Mccracken GH Jr. The role of corticosteroid therapy in children with pneumococcal meningitis. AJDC. 1991;145:1374-1378.
5. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-1531.
6. Marguet C, Mallet E. Intérêt de la dexaméthasone au cours des méningites purulentes de lenfants a propos d̀une étude comparative chez 85 enfants. Arch Fr Pediatr 1993;50:111-117.
7. Schaad UB, Lips U, Gnehm HE, Blumberg A, Heinzer I, Wedgwood. Dexamethasone therapy for bacterial meningitis in children. Lancet. 1993;342:457-461.
8. Syrogiannopoulos GA, Lourida NA, Theodoridou MC, et al. Dexamethasone therapy for bacterial meningitis in children: 2-versus 4-days regimen. J Infect Dis 1994;169:853-858.
9. Mcintyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-931.
10. Coyle PK. Glucocorticoids in central nervous system bacterial infection. Arch Neurol 1999;56:796-801.
11. Sacchi CT, Zanella RC, Caugant DA, et al. Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil. J Clin Microbiol 1992;30:1282-1286.
12. Sacchi CT, Tondella MLC, Lemos APS, et al. Characterization of epidemic Neisseria meningitidis serogroup C strains in several Brazilian States. J Clin Microbiol. 1994;32:1-5.
13. Centro de Vigilância Epidemiológica. A doença meningocócica: situação atual.http://www.cve.saude.sp.gov. br/htm/inf_meni0711.htm
14. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1989;160:818-25.
15. Waagner DC, Hoyt MJ, Finitzo T, Mccracken GH Jr. Administration of dexamethasone before antibiotic therapy in bacterial meningitis in children. N Engl J Med. 1990;322:141-147.
16. Herson VC, Todd JK. Prediction of morbidity in Haemophilus influenzae meningitis. Pediatrics 1977;59:35-39.
17. Turini TL, Baldy JLS, Passos JN, Takata PK. Fatores prognósticos da doença meningocócica: estudo relativo a 254 casos. Rev Saúde Públ S Paulo. 1979;13:173-182.
18. Tesoro LJ, Selbst SM. Factors affecting outcome in meningococcal infections. AJDC. 1991;145:218-220.
19. Gesell A, Amatruda C. Diagnostico del desarollo normal y anormal del nino. Buenos Aires: Paidos, 1962.
20. Northern JL, Downs NP. Hearing in children. 3.Ed. Baltimore: Willians & Wilkins, 1984.
21. Davis, H. Audiometric: pure tone and simple speech tests. In Hearing and deafness. New York, 3.Ed. Holt 1970:179-220.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV) 4.Ed. Washington, DC: APA Press, 1994.
23. Sell SHW, Merrill RE, Doyne EO, Zimsky EP Jr. Long-term sequelae of Hemophilus influenzae meningitis. Pediatrics 1972;49:206-211.
24. Edwards MS, Baker CJ. Complications and sequelae of meningococcal infections in children. J Pediatr 1981;99:540-545.
25. Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequel of acute bacterial meningitis. N Engl J Med 1984;311:869-874.
26. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis 1993;12:389-394.
27. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344:1378-1388.
28. Hackett SJ, Thomson APJ, Hart CA. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 2001;50:847-859.
29. Syrogiannopoulus GA, Olsen KD, Reisch JS, Mccracken GH Jr. Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis. 1987;155:213-219.
30. Tuomanen E. Molecular mechanisms of inflammation in experimental pnemococcal meningitis. Pediatr Infect Dis 1987;6:1146-1149.
31. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1989;160:818-825.
32. Mustafa MM, Ramilo O, Olsen KD, et al. Tumor necrosis factor-alpha in mediating experimental Haemophilus influenzae type b meningitis. J Clin Invest 1989;84:1253-1259.